Archive for the ‘LUNGS’ Category

Building Practice causing deaths & serious illnesses as reported in Qld Australia

Tuesday, September 18th, 2018

AN IMMEDIATE ban has been issued on a certain building practice after dozens of new cases of the disease silicosis are brought to our attention.

Recent cases of trades people contracting the life-threatening lung disease prompted the Queensland government to announce an immediate ban on dry-cutting artificial stone benchtops.

More than 20 new cases have come forward in the past three weeks alone – including six terminal cases.

Andrew White is a Gold Coast stonemason who went public with his diagnosis, urging other tradies to protect themselves.



Sunday, August 9th, 2015





cannabis oil in bottle image
The cultural narrative of many countries is one that speaks of the cannabis plant as being a legitimate threat to mental and physical health and therefore rendering it a threat to the populace — deserving to be forbidden and restricted behind government classification.

This typically archaic mentality is slowly peeling away, layer by layer, around the world. Governing bodies are starting to accept the science that recognizes the medicinal value of the plant, displaying its effectiveness against an array of disorders from the minor to the major.

In regards to the major: the internet is now abundantly flourishing with evidence — of both the anecdotal and scientific varieties — that suggests and outright proves cannabis, in all its taboo-shattering glory, is effective against tumor cells and certain types of cancer……MORE

Henry Sapiecha <<MORE HERE


Wednesday, January 12th, 2011

After drinking this tea,

Hasn’t had an attack in several years!

“How on earth do you find all these remedies?” I asked them. “Actually,” they replied, “some of the best ones find us! For example…

“A woman phoned in to our radio show with a wild-sounding asthma remedy. She’d been suffering for years, but she said her life has been totally changed by…

WILD CHERRY-BARK TEA! “She swore she hasn’t had an asthma attack since she started drinking it 5 years ago. Still, we wondered…


“Does it ever! Ever since that radio show, folks with breathing problems have been telling us THANK YOU! They say it’s great for asthma, bronchitis and coughs.”

NOTE: This unusual tea can be hard to find.

Sourced & published by Henry Sapiecha


Sunday, October 10th, 2010

Early Lung Cancer Detection:

Optical Technology Shows Potential

for Prescreening Patients at High Risk

Science (Oct. 9, 2010) — Researchers from Northwestern University and NorthShore University HealthSystem (NorthShore) have developed a method to detect early signs of lung cancer by examining cheek cells in humans using pioneering biophotonics technology.

Early detection is critical for improving cancer survival rates. Yet, one of the deadliest cancers in the United States, lung cancer, is notoriously difficult to detect in its early stages. Now, researchers have developed a method to detect lung cancer by merely shining diffuse light on cells swabbed from patients’ cheeks.

“By examining the lining of the cheek with this optical technology, we have the potential to prescreen patients at high risk for lung cancer, such as those who smoke, and identify the individuals who would likely benefit from more invasive and expensive tests versus those who don’t need additional tests,” said Hemant K. Roy, M.D., director of gastroenterology research at NorthShore.

The optical technique is called partial wave spectroscopic (PWS) microscopy and was developed by Vadim Backman, professor of biomedical engineering at Northwestern’s McCormick School of Engineering and Applied Science. Backman and Roy earlier used PWS to assess the risk of colon and pancreatic cancers, also with promising results.

The lung cancer findings are published online Oct. 5 by the journal Cancer Research. The paper will appear in print in the Oct. 15 issue.

Lung cancer is the leading cause of cancer deaths in the United States. Survival rates are high with surgical resection (removal of the tumor) but only if detected at an early stage. Currently there are no recommended tests for large population screening to detect lung cancer early. The disease is already advanced by the time most lung cancer patients develop symptoms. The five-year survival rate for lung cancer patients is only 15 percent.

PWS can detect cell features as small as 20 nanometers, uncovering differences in cells that appear normal using standard microscopy techniques. The PWS-based test makes use of the “field effect,” a biological phenomenon in which cells located some distance from the malignant or pre-malignant tumor undergo molecular and other changes.

“Despite the fact that these cells appear to be normal using standard microscopy, which images micron-scale cell architecture, there are actually profound changes in the nanoscale architecture of the cell,” Backman said. “PWS measures the disorder strength of the nanoscale organization of the cell, which we have determined to be one of the earliest signs of carcinogenesis and a strong marker for the presence of cancer in the organ.”

“PWS is a paradigm shift, in that we don’t need to examine the tumor itself to determine the presence of cancer,” added Hariharan Subramanian, a research associate in Backman’s lab who played a central role in the development of the technology.

After testing the technology in a small-scale trial, Roy and Backman focused the study on smokers, since smoking is the major risk factor related to 90 percent of lung cancer patients. “The basic idea is that smoking not only affects the lungs but the entire airway tract,” Roy said.

The study was comprised of 135 participants including 63 smokers with lung cancer and control groups of 37 smokers with chronic obstructive pulmonary disease (COPD), 13 smokers without COPD and 22 non-smokers. The research was not confounded by the participants’ demographic factors such as amount of smoking, age or gender. Importantly, the test was equally sensitive to cancers of all stages, including early curable cancers.

The researchers swabbed the inside of patients’ mouths, and then the cheek cells were applied to a slide, fixed in ethanol and optically scanned using PWS to measure the disorder strength of cell nanoarchitecture. Results were markedly elevated (greater than 50 percent) in patients with lung cancer compared to cancer-free smokers.

A further assessment of the performance characteristics of the “disorder strength” (as a biomarker) showed greater than 80 percent accuracy in discriminating cancer patients from individuals in the three control groups.

“The results are similar to other successful cancer screening techniques, such as the pap smear,” Backman said. “Our goal is to develop a technique that can improve the detection of other cancers in order to provide early treatments, much as the pap smear has drastically improved survival rates for cervical cancer.”

Additional large-scale validation trials are necessary for PWS. If it continues to prove effective in clinical trials at detecting cancer early, Backman and Roy believe PWS has the potential to be used as a prescreening method, identifying patients at highest risk who are likely to benefit from more comprehensive testing such as bronchoscopy or low-dose CT scans.

The paper is titled “Optical Detection of Buccal Epithelial Nanoarchitectural Alterations in Patients Harboring Lung Cancer: Implications for Screening.” In addition to Roy, Backman and Subramanian, other authors of the paper are Dhwanil Damania, Thomas A. Hensing, William N. Rom, Harvey I. Pass, Daniel Ray, Jeremy D. Rogers, Andrej Bogojevic, Maitri Shah, Tomasz Kuzniar and Prabhakar Pradhan.

Editor’s Note: This article is not intended to provide medical advice, diagnosis or treatment.

Sourced & published by Henry Sapiecha


Sunday, October 10th, 2010

High amounts of heavy metals found in China tobacco

By Tan Ee LynPosted 2010/10/07 at 7:55 am EDT

HONG KONG, Oct. 7, 2010 (Reuters) — Some Chinese cigarettes contain amounts of lead, arsenic and cadmium that are three times higher than levels found in Canadian cigarettes, a study has found.

While consuming such heavy metals is widely known to be harmful to health, there is little research done so far about their impact when inhaled into the body.

The researchers, who published their findings in the journal Tobacco Control on Thursday, said more investigation was needed.

“While the per-stick levels of metals are what we measured, the real issue is repeated exposure. Smokers don’t smoke just one cigarette, but 20 or so a day every day for years because cigarettes are addictive,” wrote lead author Richard O’Connor of the Roswell Park Cancer Institute in Buffalo, New York.

“These metals get into smokers along with a cocktail of other toxicants. The effect of cumulative exposure to multiple toxicants, including metals, is the public health question that needs to be sorted out.”

The researchers used Canadian cigarettes for comparison in their study because Canadian manufacturers and importers are required to test for metals content in tobacco, and Health Canada, the country’s public health agency, recently released data concerning this.

China has more than 320 million smokers and a million Chinese in the country die each year from tobacco-related illnesses. Smoking has been causally linked to hypertension, stroke, diabetes, cancer, heart and respiratory diseases, among others.

China has the world’s largest smoking population and is also the biggest producer of tobacco, manufacturing 2.16 trillion cigarettes in 2007, according to the Tobacco Atlas.

O’Connor and colleagues analyzed 78 varieties of popular Chinese cigarette brands and found significantly elevated levels of heavy metals, with some containing three times the levels of lead, cadmium and arsenic compared with Canadian cigarettes.

“The higher yields of cadmium and lead in cigarettes manufactured in China are worrisome given current smoking prevalence in China and China National Tobacco Company’s export ambitions,” the researchers wrote in their paper.

A member of the team, Geoffrey Fong from the University of Waterloo in Canada, said the heavy metals content was due to contaminated soil.

“Tobacco like other crops absorbs minerals and other things from the soil, so if the soil has cadium, lead or arsenic, they will be absorbed into the tobacco,” Fong said.

Sourced & published by Henry Sapiecha


Tuesday, June 29th, 2010

Scientists Grow New Lungs

Using ‘Skeletons’ of Old Ones

Science (June 28, 2010) — For someone with a severe, incurable lung disorder such as cystic fibrosis or chronic obstructive pulmonary disease, a lung transplant may be the only chance for survival. Unfortunately, it’s often not a very good chance. Matching donor lungs are rare, and many would-be recipients die waiting for the transplants that could save their lives.

Such deaths could be prevented if it were possible to use stem cells to grow new lungs or lung tissue. Specialists in the emerging field of tissue engineering have been hard at work on this for years. But they’ve been frustrated by the problem of coaxing undifferentiated stem cells to develop into the specific cell types that populate different locations in the lung.

Now, researchers from the University of Texas Medical Branch at Galveston have demonstrated a potentially revolutionary solution to this problem. As they describe in an article published electronically ahead of print by the journal Tissue Engineering Part A, they seeded mouse embryonic stem cells into “acellular” rat lungs — organs whose original cells had been destroyed by repeated cycles of freezing and thawing and exposure to detergent.

The result: empty lung-shaped scaffolds of structural proteins on which the mouse stem cells thrived and differentiated into new cells appropriate to their specific locations.

“In terms of different cell types, the lung is probably the most complex of all organs — the cells near the entrance are very different from those deep in the lung,” said Dr. Joaquin Cortiella, one of the article’s lead authors. “Our natural matrix generated the same pattern, with tracheal cells only in the trachea, alveoli-like cells in the alveoli, pneumocytes only in the distal lung, and definite transition zones between the bronchi and the alveoli.”

Such “site-specific” cell development has never been seen before in a natural matrix, said professor Joan Nichols, another of the paper’s lead authors. The complexity gives the researchers hope that the concept could be scaled up to produce replacement tissues for humans — or used to create models to test therapies and diagnostic techniques for a variety of lung diseases.

“If we can make a good lung for people, we can also make a good model for injury,” Nichols said. “We can create a fibrotic lung, or an emphysematous lung, and evaluate what’s happening with those, what the cells are doing, how well stem cell or other therapy works. We can see what happens in pneumonia, or what happens when you’ve got a hemorrhagic fever, or tuberculosis, or hantavirus — all the agents that target the lung and cause damage in the lung.”

The researchers have already begun work on large-scale experiments, “decellularizing” pig lungs with an eye toward using them to produce larger samples of lung tissue that could lead to applications in humans. They’re also taking on the challenge of vascularization — stimulating the growth of blood vessels that will enable the engineered tissues to survive outside the special bioreactors that the researchers now use to keep them alive by bathing them in a life-sustaining cocktail of nutrients and oxygen.

“People ask us why we’re doing the lung, because it’s so hard,” Cortiella said. “But the potential is so great, and the technology is here. It’s going to take time, but I think we’re going to create a system that works.”

Other authors of the Tissue Engineering Part A paper are UTMB research associate Jean Niles, associate professor Gracie Vargas, medical student Sean Winston, graduate student Shannon Walls, summer research fellows Andrea Brettler and Jennifer Wang, Andrea Cantu of Stanford University and Dr. Anthony Pham of Brown Medical School

Sourced & published by Henry Sapiecha


Thursday, June 17th, 2010

Red Wine May Lower Lung Cancer Risk

Science (Oct. 7, 2008) — Moderate consumption of red wine may decrease the risk of lung cancer in men, according to a report in the October issue of Cancer Epidemiology, Biomarkers & Prevention¸ a journal of the American Association for Cancer Research.

“An antioxidant component in red wine may be protective of lung cancer, particularly among smokers,” said Chun Chao, Ph.D., a research scientist at Kaiser Permanente Department of Research and Evaluation in Pasadena, California.

Chao analyzed data collected through the California Men’s Health Study, which linked clinical data from California’s health system with self-reported data from 84,170 men aged 45 to 69 years. Researchers obtained demographics and lifestyle data from surveys computed between 2000 and 2003, and identified 210 cases of lung cancer.

Researchers measured the effect of beer, red wine, white wine and liquor consumption on the risk of lung cancer. Adjustments were made for age, race/ethnicity, education, income, body mass index, history of chronic obstructive pulmonary disease or emphysema, and smoking history.

Among the study participants, there was on average a two percent lower lung cancer risk associated with each glass of red wine consumed per month. The most substantial risk reduction was among smokers who drank one to two glasses of red wine per day. The researchers reported a 60 percent reduced lung cancer risk in these men. Researchers warned men to stop smoking as the best way to reduce lung cancer risk; noting that even men who drank one to two glasses of red wine per day still face higher lung cancer risk than do non-smokers.

No clear associations with lung cancer were noted for consumption of white wine, beer, or liquor. “Red wine is known to contain high levels of antioxidants. There is a compound called resveratrol that is very rich in red wine because it is derived from the grape skin. This compound has shown significant health benefits in preclinical studies,” Chao said.

Chao said their findings should not be construed to recommend heavy alcohol consumption.

Sourced & published by Henry Sapiecha


Monday, June 7th, 2010

Surprise: A Pfizer Cancer Drug Works

June 5, 2010 – 10:53 am
Robert LangrethBio | Email
Robert Langreth is a senior editor at Forbes, in charge of health care coverage

Its been a tough couple years for Pfizer on the cancer front, as numerous cancer drugs have failed in trials. Among others, Pfizer is presenting results from a failed trial of a lung cancer drug called figitumumab.

But Saturday morning at the American Society of Clinical Oncology meeting in Chicago, Pfizer is getting some good news. A new super-targeted lung cancer drug that treats a defective gene called EML4-ALK is showing great promise in early trials. Roughly 3% to 5% of lung cancer patients, generally younger nonsmokers, have this gene alteration. Roughly 10,000 lung cancer patients in the United States may have the genetic defect in their tumors.

Of 82 lung cancer patients with the defective gene who got the drug, called crizotinib, tumors shrank dramatically in 57% of them. The trial is still ongoing, so the duration of response is unknown, but some patients have gone 15 months without disease progression. The early results are so promising that Pfizer plans to apply for approval next year, even as larger studies are still ongoing.

The defective gene driving these cancers was discovered by basic researchers in 2007. “In just three short years we have gone from a description on an oncogene to a therapy,” said Mark Kris of Memorial Sloan-Kettering Cancer Center, at a press conference. “It is an amazing example of how once we understand a cancer cell we can come up with a therapy quickly.” He compared the development of the ALK drug to the development of Gleevec, from Novartis, for leukemia. Side-effects of crizotinib include nausea, diarrhea and vomiting.

Sourced and published by Henry Sapiecha 7th June 2010


Wednesday, October 7th, 2009

Non-TB lung disease increasing in the U.S.


BETHESDA, Md. (UPI) — The U.S. National Institute of Allergy and Infectious Diseases says incidents of non-tuberculosis mycobacteria lung disease are increasing across the nation.

Researchers said non-tuberculous mycobacteria are environmental organisms found in both water and soil that can cause severe pulmonary disease in humans — and a large study indicates the disease is increasing.

A research team led by epidemiologists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, analyzed hospital discharge records of patients in 11 states whose combined total population represents 42 percent of the country. They said they reviewed database records spanning 1998 to 2005 and identified more than 16,475 hospitalizations associated with non-tuberculosis mycobacteria in people without AIDS.
Before the widespread availability of combination antiretroviral therapy, pulmonary disease was a common opportunistic infection among people with AIDS. The study was limited to patients not suffering from AIDS.

Researchers said of the 11 states studied, Florida, New York and California had 62 percent of the pulmonary hospitalizations.

Study results show while overall prevalence of non-tuberculosis mycobacteria lung disease is higher in women, prevalence increases for both sexes in the fifth or sixth decade of life, the scientists said.

The research appears in the journal Emerging Infectious Diseases.

Copyright 2009 by United Press International

Sourced and published by Henry Sapiecha 7th Oct 2009



Monday, September 7th, 2009

var gaJsHost = ((“https:” == document.location.protocol) ? “https://ssl.” : “http://www.”);
document.write(unescape(“%3Cscript src='” + gaJsHost + “’ type=’text/javascript’%3E%3C/script%3E”));

var pageTracker = _gat._getTracker(“UA-4750335-1”);

The journey from living with cancer to living
without cancer starts at Guangzhou Yu Hao


  • We have in our faculty three of China’s top
    oncologists/scientists making us one of the leading tumor
    treatment centre cand stem cell laboratory in China
  • Other hospitals have referred patients to us as a last resort
  • Ongoing research and development of new technology and
  • Effective alternative/complementary treatment to surgery,
    chemotherapy and radiotherapy
  • The quick adoption and use of advanced new medical
    technology and equipment
  • Unique methods
  • Some therapies are 100% non-invasive (no surgeries)
  • Immediate relief from severe pain (as fast as a week from
  • We can accept terminal cases (except for patients who are
    too frail to travel to China)
  • Fast results (within 30 days)
  • Minimal side-effects
  • Use of Traditional Chinese Medicine as an effective pain
    reliever and as a supplemental treatment for boosting the
    immune system
  • The best of the East and West

Some of our Pioneering Achievements:

  • The first to introduce Internal Gamma Knife or Nuclear
    Particle Knife treatment into Guangzhou – one of the most
    sophisticated cancer treatments in the world. This technology
    has been used for the last 4 years by our Chief Medical
    consultant to treat over 3000 patients successfully. The first
    Brachytherapy in Guangzhou was successfully done at our
  • The first radioactive holder therapy for esophageal
    carcinoma in Guangzhou was successfully done by us
  • The first in China to use HIFU to successfully treat liver portal
    vein cancer bolt
  • No excision required for the successful treatment of breast
  • No excision required for the treatment of rectum carcinoma
  • No excision of the esophagus required in cases of esophagus
  • The first Telemedicine center in Guangzhou where our
    expertise is made available to all
  • Special emphasis on the humane treatment of patients and
    fostering close doctor patient relationships.

china-hospital-foyer-1china-hospital-security-screenschina-hospital-foyer-2 is dedicated to helping you to
understand your options in your fight against cancer.
We hope the information provided on this website is enough for you to
make a decision to contact us to explore the best treatment plan for yourself or loved ones.

Our strength lies in bringing together three factors: vast experience, top expertise, and the latest medical technologies all in one location.

We understand that for many who have not visited China before
that the thought of going to a foreign country for treatment
may seem daunting. That is why we are committed to doing our best so that international enquiries for admission are dealt with efficiently and
quickly and we will provide the necessary information and help to ensure that you and your family’s visit and stay is most comfortable and hassle-free.

Contact Us today for
your queries.

Sourced and published by Henry Sapiecha 7th Sept 2009